
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1056 | 1064 | 1164 | 1271 | 1358 | 1736 |
Fund Return | 5.6% | 6.36% | 16.41% | 8.33% | 6.31% | 5.67% |
Place in category | 66 | 168 | 132 | 101 | 104 | 94 |
% in Category | 14 | 37 | 31 | 24 | 26 | 36 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CF Canlife Global Equity Fund C Acc | 13.9M | 5.01 | 12.37 | 11.72 | ||
CF Canlife Portfolio V Fund C Acc | 152.58M | 2.87 | 4.78 | 5.61 | ||
CF Canlife North American Fund C Ac | 15.14M | 4.36 | 13.82 | 14.06 | ||
CF Canlife Portfolio III Fund C Acc | 36.39M | 1.71 | 0.80 | 2.73 | ||
CF Canlife Portfolio III Fund C Inc | 1.31M | 1.70 | 0.81 | 2.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.03B | 6.61 | 10.97 | 7.28 | ||
TB Evenlode Income B Income | 3.01B | 3.59 | 6.59 | 7.84 | ||
UK Equity Income Fund Z Income GBP | 614.72M | 3.11 | 8.47 | 6.79 | ||
UK Equity Income Fund Retail Accumu | 114.12M | 1.63 | 8.03 | 5.61 | ||
UK Equity Income Fund Z Accumulatio | 614.86M | 3.11 | 8.46 | 6.78 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 8.32 | 11,808.0 | +1.36% | |
Shell | GB00BP6MXD84 | 8.07 | 31.21 | +1.28% | |
Unilever | GB00B10RZP78 | 6.76 | 53.66 | -1.47% | |
HSBC | GB0005405286 | 3.85 | 851.20 | +0.41% | |
National Grid | GB00BDR05C01 | 3.75 | 952.20 | -0.08% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review